MYUNGMOON Pharm co.,Ltd (KOSE:A017180) announces a share repurchase program. Under the program, the company will repurchase up to KRW 1,000 million worth of its shares, pursuant to a trust contract with DAISHIN Securities Co., LTD. The purpose of the program is to stabilize stock price and uplift the value of shareholders. The program will expire on November 25, 2023.

As of May 24, 2023, the company had 147,664 shares in treasury within scope available for dividend and had no shares in treasury under other capacities.